STOCK TITAN

Cue Health to Announce Third Quarter 2022 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Cue Health Inc. (Nasdaq: HLTH) will release its third quarter 2022 financial results on November 9, 2022. A conference call and webcast will follow at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and recent highlights. Investors can register for the live call online, and a replay will be available afterward on the company’s website. Cue Health, a healthcare technology company, specializes in accessible health information and diagnostics, with products including the first FDA-authorized at-home COVID-19 test.

Positive
  • Scheduled Q3 2022 financial results release may indicate upcoming growth or positive developments.
  • The conference call provides an opportunity for investors to gain insights into company performance.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its third quarter 2022 financial results on Wednesday, November 9, 2022. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

To access the live call via telephone, please register in advance using the link here. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call.

The live webinar of the call may be accessed by visiting the Events section of the Company’s website at investors.cuehealth.com. A replay of the webinar will be available on the Company’s website shortly after the conclusion of the call.

About Cue Health
Cue Health (Nasdaq: HLTH) is a healthcare technology company that makes it easier for individuals to access health information and places diagnostic information at the center of care. Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India's Central Drugs Standard Control Organization, and PSAR authorization from Singapore's Health Sciences Authority. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.

Lorna Williams ir@cuehealth.com

858-667-4934 (ext. 1104)

Cue Health press@cuehealth.com

Source: Cue Health Inc.

FAQ

When will Cue Health release its Q3 2022 financial results?

Cue Health will release its Q3 2022 financial results on November 9, 2022.

What time is the Cue Health conference call for Q3 2022 results?

The conference call will take place at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can I access Cue Health's conference call?

Investors can register for the conference call via a link provided in the press release.

What is the stock symbol for Cue Health?

Cue Health's stock symbol is HLTH.

Is there a replay available for Cue Health's conference call?

Yes, a replay of the conference call will be available on Cue Health's website shortly after the call.

Cue Health Inc.

NASDAQ:HLTH

HLTH Rankings

HLTH Latest News

HLTH Stock Data

6.90M
159.09M
11.57%
52.81%
0.49%
Health Information Services
Laboratory Analytical Instruments
Link
United States of America
SAN DIEGO